Dec 13


Pharmaceutical powerhouse Merck is researching traditional Chinese medical treatments to develop cancer drugs:

“German pharmaceutical giant Merck announced last week that it would collaborate with a Chinese pharmaceutical company to develop new cancer drugs based on traditional Chinese herbs and botanical medicines.

Hong Kong-based Chi-Med — a pharmaceutical firm that develops consumer health products from natural ingredients used in Traditional Chinese Medicine (TCM) — said it will team with Merck to find potential cancer drugs among roughly 10,000 herbal TCM compounds. However, critics say the partnership will only serve to allow Merck to generate more profits from “pirated” natural plant chemicals sold as expensive pharmaceuticals.

Consumer health advocate Mike Adams, author of “Take Back Your Health Power,” said Merck’s partnership with Chi-Med would result in the company locating, copying and patenting chemicals found in Chinese herbs, then selling them as prescription drugs.

“When Chinese firms steal intellectual property from the United States, we call it piracy, but when drug companies acquire medical know-how from Chinese medicine, it’s called research,” Adams said. “But let’s be clear here — I don’t believe Merck is about to start promoting Chinese herbal cures for anything. ”

Related posts:

  1. Western drugs derived from Chinese herbs
  2. Cancer treatment using alternative medicine
  3. Chinese medicine and cancer treatment
  4. Traditional Chinese medicine research
  5. Capitalizing on Chinese herbs

Comments are closed.

 
preload preload preload